Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Asmita Pal, Rita Kundu
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 451

Showing 1-25 of 451 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 468
Cervical cancer therapies: Current challenges and future perspectives
Carly A. Burmeister, Saif F. Khan, Georgia Schäfer, et al.
Tumour Virus Research (2022) Vol. 13, pp. 200238-200238
Open Access | Times Cited: 250
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
Paul Shafer, Lauren Kelly, Valentina Hoyos
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 151
APOBEC: A molecular driver in cervical cancer pathogenesis
Sundaramoorthy Revathidevi, Avaniyapuram Kannan Murugan, Hirofumi Nakaoka, et al.
Cancer Letters (2020) Vol. 496, pp. 104-116
Open Access | Times Cited: 149
Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
Rahul Bhattacharjee, Sabya Sachi Das, Smruti Sudha Biswal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 174, pp. 103675-103675
Open Access | Times Cited: 118
mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
Sanne Bevers, Sander A.A. Kooijmans, Elien Van de Velde, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 3078-3094
Open Access | Times Cited: 89
Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins
Daria Haręża, Jacek R. Wilczyński, Edyta Paradowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1818-1818
Open Access | Times Cited: 77
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Qiaofei Liu, Jiayi Li, Huaijin Zheng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives
Shopnil Akash, İmren Bayıl, Md. Saddam Hossain, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 2
Tumor Immunity and Immunotherapy for HPV-Related Cancers
A. Shamseddine, Bharat Burman, Nancy Y. Lee, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 1896-1912
Open Access | Times Cited: 70
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
Ban Qi Tay, Quentin G. Wright, Rahul Ladwa, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 535-535
Open Access | Times Cited: 56
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
Manuel Rodrigues, Giulia Vanoni, Pierre Loap, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer
Miriam Reuschenbach, John Doorbar, Marta del Pino, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6194-6205
Open Access | Times Cited: 34
The complexity of human papilloma virus in cancers: a narrative review
Vahideh Hamidi Sofiani, Parsa Veisi, Mohammad Rezaei Zadeh Rukerd, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 24
Navigating therapeutic strategies: HPV classification in head and neck cancer
Hossein Tabatabaeian, Yuchen Bai, Ruihong Huang, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 220-230
Open Access | Times Cited: 15
Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction
Raafat M. Munshi
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296107-e0296107
Open Access | Times Cited: 14
Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential
Roujie Huang, Zimo Liu, Tianshu Sun, et al.
Microbiological Research (2024) Vol. 287, pp. 127857-127857
Open Access | Times Cited: 10
A Landscape of Cancer Initiation and Cancer Stem Cells
Masaharu Seno
Cancers (2025) Vol. 17, Iss. 2, pp. 203-203
Open Access | Times Cited: 1
The differential role of aryl hydrocarbon receptor in skin cancers induced by environmental carcinogens, including ultraviolet irradiation, arsenic exposure, and HPV infection
Han‐Chi Tseng, Po‐Ta Lai, Chih‐Hung Lee
Dermatologica Sinica (2025)
Open Access | Times Cited: 1
Recent update on the Development of HPV16 inhibitors for Cervical Cancer
Muhammad Shoaib, Amina Tariq, Yanchen Liu, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104703-104703
Closed Access | Times Cited: 1
CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions
Abu Hazafa, Muhammad Mumtaz, Muhammad Farooq, et al.
Life Sciences (2020) Vol. 263, pp. 118525-118525
Open Access | Times Cited: 69
The Biological Activities and Therapeutic Potentials of Baicalein Extracted from Oroxylum indicum: A Systematic Review
Nik Nur Hakimah Nik Salleh, Farah Amna Othman, Nur Alisa Kamarudin, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5677-5677
Open Access | Times Cited: 58
Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
Mariam Oladejo, Yvonne Paterson, Laurence M. Wood
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54
Targeted Gene Delivery Therapies for Cervical Cancer
Ángela Ayén, Yaiza Jiménez Martínez, Houría Boulaiz
Cancers (2020) Vol. 12, Iss. 5, pp. 1301-1301
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top